LCOV
ABBV icon

London Company of Virginia’s AbbVie ABBV Stock Holding History

London Company of Virginia’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,172
Closed -$337K – 128
2017
Q1 		$337K Buy
+5,172
New +$325K ﹤0.01% 119

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

London Company of Virginia's ABBV Position: Q2 2017 in Review

London Company of Virginia sold out of AbbVie (ABBV) in Q2 2017, closing a stake of 5,172 shares — an estimated $337K sold.

London Company of Virginia first reported a position in ABBV in Q1 2017 and held it in 1 quarter. The position peaked at $337K in Q1 2017. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

  • London Company of Virginia reported no remaining AbbVie position as of Q2 2017 after selling out during the quarter.
  • London Company of Virginia sold 5,172 AbbVie shares in Q2 2017, an estimated $337K.
  • London Company of Virginia first reported a position in AbbVie in Q1 2017 and held it in 1 quarter.
  • London Company of Virginia's AbbVie position peaked at $337K in Q1 2017.
  • 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on London Company of Virginia's 13F filing for Q2 2017, filed 14 Aug 2017.